Back to today’s briefing

Story perspectives

Stimulant Shortage Linked to ADHD Overdiagnosis and Rising Claim Denials

6/14/2025

33 3

Summary

Story summary

A March 2025 commentary in Population Health, Equity & Outcomes reveals that the stimulant shortage is tied to the overdiagnosis of adult ADHD, stemming from unclear criteria for executive functioning deficits. Meanwhile, a Fierce Healthcare report uncovers a troubling 16% increase in insurance claim denials from 2018 to 2024, exacerbating the health and financial burdens faced by patients across the US.

1 of 1

Story summary

A March 2025 commentary in Population Health, Equity & Outcomes reveals that the stimulant shortage is tied to the overdiagnosis of adult ADHD, stemming from unclear criteria for executive functioning deficits. Meanwhile, a Fierce Healthcare report uncovers a troubling 16% increase in insurance claim denials from 2018 to 2024, exacerbating the health and financial burdens faced by patients across the US.